União Química Farmacêutica Nacional’s BRL330 Million Financing

Becker, Glynn, Muffly, Chassin & Hosinski LLP acted as New York counsel to International Finance Corporation (IFC) on its granting of a BRL330 million financing package to União Química Farmacêutica Nacional S.A. (União Química).

Founded in 1936, União Química is one of Brazil’s largest and most robust pharmaceutical companies. The IFC loan will be used to further the expansion of União Química’s production capacity, vaccine infrastructure and energy efficiency projects. This will be achieved by directing funds towards the modernisation of the company’s plants and the boosting of its production capacity for vaccines and medicines, furthering União Química’s goal to join the international vaccination system and offer immunisers to Latin American nations.

The Becker Glynn team was led by partner Peter Hosinski and associate Tianpu Zhang, who (along with other firm members) addressed, inter alia, the drafting intricacies related to a real-denominated loan that was repayable in dollar-equivalent amounts.

You might also like

Comments are closed.